Jeremy Fenton, MD
Dermatology · New York, NYNPI 1598909277
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $13,359 of the $16,427 with a category attached, or 81.3%. It is spread thinly across 36 manufacturers, the largest accounting for just 20.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $6,211 and has fallen 57.4% since, to $2,649 in 2025.
Across 697 payments — averaging $23.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$3K
- AbbVie$2K
- Novartis$2K
- Johnson & Johnson$2K
- Amgen$870
- E.r. Squibb & Sons, L.L.C.$854
- plus $6K from 30 others
What the payments were for
- Consulting fees$2,85317%
- Food & beverage$13,35981%
- Education$2151%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 20 | $3,307 |
| AbbVie | 102 | $2,020 |
| Novartis | 88 | $1,680 |
| Johnson & Johnson | 79 | $1,530 |
| Amgen | 40 | $870 |
| E.r. Squibb & Sons, L.L.C. | 41 | $854 |
| Lilly USA, LLC | 44 | $811 |
| Biofrontera Inc. | 37 | $689 |
| Sun Pharmaceutical Industries Inc. | 36 | $575 |
| Dermavant Sciences, Inc. | 32 | $557 |
| Arcutis Biotherapeutics, Inc. | 24 | $508 |
| Pfizer | 22 | $468 |
| LEO Pharma Inc. | 22 | $413 |
| Sanofi | 18 | $395 |
| Galderma Laboratories, L.p. | 19 | $372 |
| UCB, Inc. | 12 | $235 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 12 | $230 |
| Mayne Pharma Commercial LLC | 11 | $138 |
| Incyte Corporation | 6 | $125 |
| Verrica Pharmaceuticals Inc. | 5 | $108 |
| Smith+Nephew | 4 | $104 |
| Almirall LLC | 4 | $66 |
| Organon | 2 | $55 |
| VYNE Pharmaceuticals Inc. | 2 | $45 |
| Encore Dermatology Inc. | 2 | $43 |
| Bristol Myers Squibb | 2 | $36 |
| Strata Skin Sciences, Inc. | 2 | $27 |
| Prugen, Inc. Pharmaceuticals | 1 | $23 |
| Cipher Pharmaceuticals US LLC | 1 | $21 |
| EPI Health, LLC | 1 | $21 |
| Botanix SB Inc | 1 | $20 |
| Boehringer Ingelheim | 1 | $19 |
| Fidia Pharma USA Inc. | 1 | $18 |
| Novum Pharma, LLC | 1 | $16 |
| Merck | 1 | $16 |
| Mylan Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,427 in reported general payments places this provider in the 80th percentile of 1,151 dermatology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 14 | $47,090 |
| Clobetasol Propionate | 89 | $4,574 |
| Ketoconazole | 111 | $2,277 |
| CiclopiroxCiclopirox Olamine | 36 | $1,602 |
| Triamcinolone Acetonide | 127 | $1,295 |
| Fluorouracil | 18 | $1,231 |
| Mupirocin | 147 | $1,130 |
| Ciclopirox | 25 | $1,098 |
| Tretinoin | 12 | $787 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 12 | $523 |
| Clindamycin Phosphate | 18 | $433 |
| ValacyclovirValacyclovir Hcl | 19 | $291 |
| Mometasone Furoate | 12 | $243 |
| Doxycycline Hyclate | 13 | $103 |
| Hydrocortisone | 18 | $93 |
Paid to pharmacies, not to this prescriber.
Other dermatology in New York
- Alexandra GolantNew York$3.6M
- David CohenNew York$3M
- Michael CameronNew York$2.6M
- Saakshi KhattriNew York$2.4M
- Amy WechslerNew York$2.4M
- Joshua ZeichnerNew York$2.1M
- Emma GuttmanNew York$1.7M
- George HanNew York$1.6M
- Amy SpizuocoNew York$1.3M
- Andrew AlexisNew York$834K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.